Please sign in to follow a disease.
New pain block study aims to cut morphine use after breast cancer surgery
NCT ID NCT07362472
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different nerve block techniques to manage pain after breast cancer surgery. Sixty women received either an erector spinae plane block or a combination of serratus anterior and pecto-intercostal fascial plane blocks. Researchers measured how much morphine each group needed in the first 24 hours after surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Female patients undergoing major breast cancer surgeries (modified radical mastectomy, breast reconstruction with implants). * American society of anesthesiologist Grade 1 \& 2 * Age between 18 to 45 years Exclusion Criteria: * Patient's refusal * Emergency cases * Patients having uncontrolled diseases like asthma, COPD or other lung diseases * History of allergy from the drugs being used during the study * Pregnant patients * Patients with coagulopathies/bleeding disorders * Patients undergoing bilateral major breast cancer surgery.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Shaukat Khanam Memorial Cancer Hospital & Research Centre Lahore
Lahore, Punjab Province, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?